CXCL12 and cancer: The chemokine receptor CXCR4 and its ligand CXCL12, also known as stromal cell-derived factor 1 (SDF-1), are attractive therapeutic targets in the treatment of cancer, as they support migration, proliferation, and survival of cancer cells (Teicher and Fricker, 2010; Domanska et al., 2013).